SCHEMBL3832078

SCHEMBL3832078

O=Cc1cnc2c(c1)NCCN2

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NNMT P40261 2/20 0.33
GRM5 P41594 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29951191 0.76 NNMT (0.53) NNMTGRM5
SCHEMBL6425767 0.74 NNMT (0.55) NNMTGRM5
SCHEMBL15653050 0.73 MAP4K1 (0.41) GRM5
SCHEMBL21605734 0.73 GRM5 (0.50) GRM5
SCHEMBL5253609 0.73 MEN1 (0.32)
SCHEMBL16823386 0.71 NNMT (0.35) NNMTGRM5
SCHEMBL1602453 0.71 KDM4E (0.33) NNMTGRM5
SCHEMBL20595712 0.71 HTT (0.34) NNMTGRM5
SCHEMBL19908287 0.71 ALDH1A1 (0.35) NNMTGRM5
SCHEMBL29712705 0.69 NNMT (0.49) NNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2091951-A2 PYRIDO[2,3-B]PYRAZINE AND[1,8]-NAPHTYRIDINE DERIVATIVES AS ALK AND C-MET INHIBITORS CEPHALON, INC. (US) 2009-08-26 EP claimed
WO-2007130468-A2 PYRIDO [2, 3-B] PYRAZINE AND [1, 8] -NAPHTHYRIDINE DERIVATIVES AS ALK AND C-MET INHIBITORS CEPHALON, INC. (US) 2007-11-15 WO claimed
EP-2091951-A2 PYRIDO[2,3-B]PYRAZINE AND[1,8]-NAPHTYRIDINE DERIVATIVES AS ALK AND C-MET INHIBITORS CEPHALON, INC. (US) 2009-08-26 EP disclosed
WO-2007130468-A2 PYRIDO [2, 3-B] PYRAZINE AND [1, 8] -NAPHTHYRIDINE DERIVATIVES AS ALK AND C-MET INHIBITORS CEPHALON, INC. (US) 2007-11-15 WO disclosed